Alzheimers Disease Clinical Trials

40 clinical trials for Alzheimers Disease across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — RECRUITING · PHASE3
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — RECRUITING · PHASE3
• Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers — RECRUITING · PHASE2
• A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation — RECRUITING · PHASE2
• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation — RECRUITING · PHASE2
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — RECRUITING · PHASE3
• Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD) — RECRUITING · NA
• Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease — RECRUITING · NA
• Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease — RECRUITING · PHASE2
• EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES — RECRUITING · NA
• A Post Authorization Registry Study of Participants Treated With LEQEMBI — NOT_YET_RECRUITING
• University of Central Florida Music Study — COMPLETED · NA
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 — ACTIVE_NOT_RECRUITING · PHASE2
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) — ACTIVE_NOT_RECRUITING · PHASE2
• Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease — ACTIVE_NOT_RECRUITING · PHASE1
• A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease — COMPLETED · PHASE3
• Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease — WITHDRAWN · NA
• The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab. — NOT_YET_RECRUITING · PHASE2
• A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease — NOT_YET_RECRUITING · PHASE2
• Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD Registry) — NOT_YET_RECRUITING
• A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD) — TERMINATED · PHASE3
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation — TERMINATED · PHASE2
• An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US — TERMINATED
• Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care — COMPLETED · PHASE4
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. — COMPLETED · PHASE2
• A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants — COMPLETED · PHASE1
• A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — TERMINATED · PHASE2
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — TERMINATED · PHASE2
• Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects — COMPLETED · PHASE1
• Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures — COMPLETED
• Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders — COMPLETED
• The Feasibility of Florbetapir Quantitation — COMPLETED · PHASE4
• Cognitive Behavioural Therapy for Persons With MCI or Mild Dementia — OTHER · NA
• Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type — OTHER
• A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 — TERMINATED · PHASE1
• A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 — TERMINATED · PHASE1
• Identifying Potential Effects of Liraglutide on Degenerative Changes — COMPLETED · NA
• Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression — OTHER
• Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls — COMPLETED · PHASE1
• Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects — COMPLETED · PHASE1

Refine this search